The U.S. Defense Dept. said yesterday that it awarded a contract worth $71 million to Boston Scientific (NYSE:BSX).
The agreement calls for Marlborough, Mass.-based Boston Scientific to provide cardiovascular products to the U.S. Army, Navy, Air Force, Marine Corps and federal civilian agencies. The deal has a 1-year base contract with 4 1-year renewal options, according to the Defense Dept.
